H.C. Wainwright Reiterates Buy Rating, $7 PT on Mustang Bio (MBIO), Sees MB-102 in AML and MDS as Key Opportunity
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $7.00 price target on Mustang Bio (NASDAQ: MBIO), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
